The Veterans Spinal Trauma Access to New Devices Act, or Veterans STAND Act, would amend title 38 of the U.S. Code to require the Department of Veterans Affairs to offer an annual preventive health evaluation to any veteran with a spinal cord injury or disorder who chooses to receive it. The evaluation could be provided directly, by referral, or through VA telehealth, and would cover risk factors for complications, comorbidities, chronic pain, diet and weight management, prosthetic needs and safety, and the possible use of assistive technologies.
The bill also expands the VA’s focus on advanced assistive technologies for spinal cord injury patients, including powered mobility devices, speech-generating devices, powered exoskeletons, spinal cord neuromodulation, non-invasive transcutaneous spinal stimulation, and certain FDA-approved implantable spinal cord stimulation systems. It directs the VA to consult with spinal cord injury specialists, technologists, veterans’ organizations, and, where relevant, manufacturers when issuing guidance, and it requires periodic reporting to Congress on utilization, outcomes, and evaluation rates. The bill further instructs the VA to consider these evaluations in performance metrics for Veterans Integrated Service Networks.
If enacted, the bill would create a new annual preventive evaluation benefit within the VA health system for veterans with spinal cord injuries or disorders and would codify a broader framework for assessing and providing assistive technologies. It would affect VA medical care policies, telehealth delivery, prosthetic and sensory aid practices, and internal performance measurement, while also imposing reporting obligations to the House and Senate Committees on Veterans’ Affairs. The bill does not create a new entitlement outside the VA system, but it would likely increase screening, referrals, and access to emerging rehabilitation technologies for eligible veterans.
The available context suggests generally favorable treatment of the bill, with the measure having been referred to the Senate Committee on Veterans’ Affairs and hearings held. The text is framed as a veterans’ access and innovation bill, emphasizing preventive care, improved function, and expanded access to modern devices and therapies. No recorded votes or opposing statements are provided in the materials, so the overall sentiment appears supportive or at least noncontroversial at the committee stage.
The main areas that could generate debate are the scope of the VA’s obligations, the inclusion of newer or less-established technologies such as spinal cord neuromodulation and non-invasive transcutaneous spinal stimulation, and the administrative burden of annual evaluations, consultations, and reporting. Potential concerns may also involve cost, clinical evidence, device approval standards, and how broadly the VA should interpret “assistive technology.” The bill anticipates some of these issues by requiring consultation with clinicians, technologists, veterans’ organizations, and manufacturers before issuing guidance.